Nexalin Technology, Inc.

US$1.47As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NXLHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (52.91%)
Div yield —
ROE (240.25%)
Medical Devices
Beta (5Y) 4.34
PE TTM —
TSR TTM (96.73%)
Mkt cap US$1.219M
ROIC (152.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.79
21.76%
(71.92%)
Hold 7|9|10|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
5.08%
2.62%
7.24%
7.94%
Revenue$M
0.062
0.062
0.064
0.068
4.11%
2.06%
7.01%
14.02%
Peers (US$1.219M)
Cap (US$)
PE
1.856M
—
1.441M
—
Capital
TTM
5Y
10Y
Leveragex
0.323
(0.039)
(0.031)
EBIT/Intx
1.983
0.373
0.394
Own earn%
(20.53)
12.27
15.14
Sh yield%
34.44
42.22
49.97
Owners
Insiders/Inst%
0.32
61.24
Short interest%
0.60
SBC / revenue%
0.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
6